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ABSTRACT 
 
 
Background 
The health care for patients having two or more long-term 
medical conditions is fragmented between specialists, allied 
health professionals, and general practitioners (GPs), each 
keeping separate medical records. There are separate 
guidelines for each disease, making it difficult for the GP to 
coordinate care. The TrueBlue model of collaborative care 
to address key problems in managing patients with 
multimorbidity in general practice previously reported 
outcomes on the management of multimorbidities. We 
report on the care plan for patients with depression, 
diabetes, and/or coronary heart disease that was 
embedded in the TrueBlue study. 
 
Methods  
A care plan was designed around diabetes, coronary heart 
disease, and depression management guidelines to prompt 
implementation of best practices and to provide a single 
document for information from multiple sources. It was 
used in the TrueBlue trial undertaken by 400 patients (206 
intervention and 194 control) from 11 Australian general 
practices in regional and metropolitan areas. 
 
Results  
Practice nurses and GPs successfully used the care plan to 
achieve the guideline-recommended checks for almost all 
patients, and successfully monitored depression scores and 
risk factors, kept pathology results up to date, and identified 
patient priorities and goals. Clinical outcomes improved 
compared with usual care. 
 
Conclusion 
The care plan was used successfully to manage and 
prioritise multimorbidity. Downstream implications include 
improving efficiency in patient management, and better 
health outcomes for patients with complex 
multimorbidities. 
 
Key Words 
Multimorbidity, care plans, collaborative care, diabetes, 
heart disease, depression 
 
Implications for Practice:  
1. What is known about this subject?  
Medicare-funded care plans generally fail to deal with 
multiple diseases, track changes over time, omit 
personalised goals, miss supporting self-management, and 
don’t provide specific prompts for recommended checks. 
 
2. What new information is offered in this report? 
A care-plan template developed from multiple disease 
guidelines was successfully used to manage multimorbidity, 
summarising information from multiple sources and 
involving patient participation in disease management. 
 
3. What are the implications for research, policy, or 
practice?  
GP practices should consider a combined care-plan 
approach similar to the plan reported here with its 
automatic prompts to ensure better adherence to the 
recommended checks. 
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Background 
Multimorbidity, the co-occurrence of multiple medical 
conditions in an individual,1 is becoming the norm for older 
people. One-third of 65-year-olds have three or more 
chronic conditions.2 Patients with multimorbidity have 
poorer quality of life, greater loss of physical function, and 
are prescribed multiple drugs with consequent difficulties 
with adherence. These patients are more likely to be 
admitted to and have longer stays in hospital.3 They already 
form the majority of GP workload in primary care, with 
more than half of patient encounters dealing with managing 
chronic conditions,4 and this will increase as the population 
ages.5,6 Recent articles7,8 have highlighted that it is both 
timely and important to examine practical ways to better 
manage the healthcare of patients with multimorbidity.  
 
One difficulty is that treatment guidelines are based on 
research focussed on single diseases that specifically 
exclude patients with multimorbidity. This can lead to 
conflicting management guidelines—such as using non-
steroidal anti-inflammatory medication for the treatment of 
osteoarthritis pain9 while avoiding the same medications in 
the presence of heart failure10—that do not account for the 
complexities of living with overlapping medical conditions.3 
As a result, patients undergo multiple investigations and 
find their health care fragmented between multiple 
specialist clinics, allied health providers, and general 
practice. The location of these services adds an additional 
travel burden, especially in rural or regional areas. With the 
fragmentation of health care, important comorbidities can 
be missed, such as depression, which is overrepresented 
and underdiagnosed in patients presenting with other 
chronic diseases.11 Individual preferences are often 
overlooked with targets being simply medical ones without 
the patient’s wishes and lifestyle preferences being 
considered. 
 
The key question for patients with multimorbidity is how 
high quality and coordinated care can be achieved in 
healthcare services in the face of such fragmentation of 
care.12 The TrueBlue model of collaborative care13–16, in a 
large, multicentre study undertaken in Australia, provided a 
means to address this question.  
 
The TrueBlue study 
Collaborative care has been recognised as a successful 
systematic approach to the management of depression.17 
The TrueBlue model of collaborative care used the 
principles of chronic disease management18 that call for 
timetabled reviews, a single case-manager, new roles for  
 
practice nurses, a way to exchange information between all 
members of the healthcare team, and a combined guideline 
for type 2 diabetes, coronary heart disease (CHD), and 
depression. The TrueBlue model is described in detail 
elsewhere;13,15 a brief description is provided here.  
 
Patients were screened for depression by completing the 
Patient Health Questionnaire 9 (PHQ-9)19 in the waiting 
room before attending a 45-minute nurse consultation, 
followed by a 15-minute GP consultation. In each nurse 
consultation, pathology results, clinical measurements, and 
lifestyle risks were documented and referrals to allied 
health, specialist services, or mental-health workers were 
arranged. Patient priorities, goal setting, and problem 
solving were key components of the TrueBlue model. 
Nurses worked with patients during the consultation to 
enable them to think about their personal priorities and the 
barriers to and enablers of better lifestyle choices. Nurses 
used problem-solving techniques to help patients set 
personal SMART (specific, measurable, attainable, realistic, 
and time-bound) goals that patients felt were achievable to 
assist in reducing their risk factors. Nurses reviewed and 
updated these goals with patients during each subsequent 
consultation. GP clinical decisions were based on these 
patient priorities. Importantly, this entire process was 
repeated every three months by automatically timetabling 
recall visits. The costs for the nurse time were covered 
through Australian Medicare rebates for chronic disease 
management.  
 
Care plans are known to be important in managing chronic 
disease20 and lead to improved patient outcomes21 and 
reduced hospitalisation.22 However, typical Australian GP 
management plans (GPMPs), such as a suggested blank 
GPMP template,23 do not report the patient’s wishes and 
lifestyle preferences, focussing instead on medical targets 
and management goals, nor do they track the achievement 
or partial achievement of personal lifestyle goals. Such 
GPMPs only contain a snapshot of information taken at the 
time of the consultation and do not track the changes over 
time that allow progress to be easily reviewed. Many such 
GPMPs are disease-specific and do not incorporate the 
varied requirements of multiple diseases that follow 
multiple guidelines. They do not have built-in prompts that 
guide the clinician through the various guideline-
recommended checks. A new care-plan template was 
designed to address these issues as part of the TrueBlue 
study to assist in the management of multimorbidity. We 
report here on the implementation of that care plan, and 
provide details of its integration into clinical practice.  
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Methods 
The care-plan template (Figure 1) was specifically developed 
to acquire all necessary information and provide it in a 
single document. It was designed around the overlapping 
management tasks, targets, and lifestyle changes 
recommended by the National Heart Foundation of 
Australia, Diabetes Australia, and the MacArthur 
Foundation for Depression so that it could act as a guide for 
the clinician through routine scheduling of tests and 
activities required for each patient.  
 
The care plan was designed to be capable of summarising 
clinical data, identifying clinical priorities, recording 
patient’s personal goals, coordinating the broader 
healthcare team, and providing de-identified audit data that 
could be used for research or for feedback to the clinic. It 
allowed tracking changes over time enabling the clinicians 
to monitor medication, referrals, adherence to the 
treatment plan, and attendance at external referrals. The 
care plan recorded patient’s personal goals and 
preferences, and the barriers and enablers to achieving 
these. It allowed depression to be monitored and whether 
stepped care was occurring through medication 
management and mental-health worker referrals and 
attendance. The care plan incorporated an automatic recall 
visit rather than relying on patients making the next 
appointment on an ad-hoc basis. Importantly, it 
incorporated automatic prompts to the health professionals 
to make sure that all this information was acquired. 
 
The care plan was tested in the D_TECT trial in six rural 
Australian general practices14 before being used in the 
TrueBlue randomised trial with usual GP care as a control.15 
 
Results 
Four hundred patients (206 in the intervention and 194 in 
the control) with depression and one or both of diabetes 
and CHD from 11 general practices in regional and 
metropolitan settings commenced the TrueBlue trial. 
Practices ranged from small, single GP practices to large, 
multi-GP clinics, with five (three intervention, two control) 
of the practices coming from a regional area and six (two 
intervention, four control) from a metropolitan area.15 Data 
collection commenced in 2009 and was completed in 2011. 
Approximately 72 per cent of patients (142 in the 
intervention and 147 in the control) completed the study. 
 
Table 1 presents the comparison between the control and 
intervention groups of the checks recommended by the 
National Heart Foundation and Diabetes Australia that were 
included in the combined guideline for CHD, diabetes, and 
depression management. Near-perfect recording occurred 
when the care plan was used. The intervention data were 
those recorded at the end of the 12-month study. The 
usual-care data from the control group were retrospectively 
extracted at baseline before their nurses were trained in the 
TrueBlue model and started using its care plan. Usual-care 
depression and exercise rates were not available because 
there was no system for recording exercise rates in usual 
care and patients were specifically screened for depression 
as part of their recruitment into the TrueBlue RCT. 
 
Table 1: Comparison between the control and intervention 
groups for the guideline-recommended checks 
 Control group TrueBlue 
Item recorded N* n§  N n  
Smoking 114 110 96% 142 142 100% 
Alcohol 114 42 37% 142 107 75% 
Height & weight 114 103 90% 142 142 100% 
Blood pressure 114 112 98% 142 142 100% 
Foot checks 94 34 36% 80 80 100% 
Eye checks 94 30 32% 80 79 99% 
Renal function 75 64 85% 80 80 100% 
Lipids 114 110 96% 142 141 99% 
HbA1c 75 67 89% 80 80 100% 
Depression† – – – 142 140 99% 
Exercise‡ – – – 142 142 100% 
†Usual-care depression scores were not available for the 
control group because patients were screened for 
depression as part of the recruitment process.  
‡ Baseline exercise rates were not available for the control 
group. 
* The total number of patients for whom checks could be 
performed (N) varies as not all checks were required for 
patients without diabetes. 
§ n is the number of patients for whom checks were 
performed. 
 
Discussion 
The TrueBlue model was successful in its primary aim that 
patients using its model of care showed a clinically-
significant improvement in depression.15 Improved 10-year 
cardiovascular risk, exercise rates, and referrals to exercise 
programmes and mental-health workers were also 
observed. Personal lifestyle goals were set by almost all (96 
per cent) of intervention patients. Nurses, GPs, and patients 
found that the care plan provided a structure for teamwork 
and communication between the healthcare providers and 
patients, and the information and prompts within it ensured 
a comprehensive approach to care16. 
 
The prompts in the care plan ensured that the practice 
nurses were able to successfully perform the combined-
guideline-recommended checks for CHD, diabetes, and 
depression management, with a near-complete reporting of 
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the recommended checks in the intervention group (Table 
1). This contrasts with the reduced level of reporting 
observed in the usual care undertaken by the control group, 
especially for eye and foot checks. This may be simply due 
to control clinics not reporting existing data but our “usual-
care” rates are consistent with those reported for blood 
pressure (93 per cent), renal function (69 per cent), HbA1C 
(82 per cent), and lipids (90 per cent) observed in a recent 
study of patients with diabetes24 prior to an audit cycle with 
training in the management of diabetes.  
 
Rates of depression screening in usual care could not be 
obtained in the control clinics because their patients were 
screened and their scores recorded as part of the 
recruitment phase. However, rates as low as 19 per cent in 
usual care have been reported.25 
 
Multimorbidity shifts the focus from an index disease to the 
cumulative combination of many diseases.27 Consequently, 
patient priorities will be a greater part of the decision-
making process. Our care plan ensured that patient 
priorities and goals were identified for almost all patients.  
 
Care plans can be generated online,26 but there are 
difficulties because online systems must be general enough 
to encompass all likely variations in data, leading to complex 
data entry. Consequently, the care plan used in the 
TrueBlue study was deliberately incorporated into the 
letter-writer component of each practice’s clinical software 
that automatically populated the care plan with existing 
data from the electronic medical record and additional 
measures obtained during each patient’s visit. It also 
generated a table of de-identified data that could be 
exported to the research team. Automating these tasks 
made time available to the practice nurses to build 
therapeutic relationships with their patients.  
 
To allow patients to be more proactive in improving their 
health, it was important that the care plan be kept short 
and non-technical with a view to being readable by the 
patient so that they had an overview of all their medical 
conditions. However, it was also important that it still 
remain a useful summary for the patient’s clinical team.  
 
When designing a care plan where multiple guidelines 
conflict in their advice, GPs will need to use clinical 
judgement to determine which targets should be 
followed.5,7 However, a well-constructed care plan 
developed using clinical judgement can assist GPs to 
undertake these tasks. GPs will need to use their skills as 
generalists and their expertise in longitudinal care together  
 
with their unique knowledge of each patient’s history to 
best manage the complexities of multimorbidity. 
 
Several components should be considered when developing 
the care plan. The following items were found to be 
necessary to achieve the improvements that were observed 
in the TrueBlue study: 
 
 Multiple guidelines need to be formulated into a single 
care plan into which practice nurses collate and enter 
information. GPs will need to use clinical judgement to 
determine which targets should be followed. 
 Patient priorities need to be determined and SMART 
goals developed and written into the care plan to assist 
GPs to make appropriate clinical decisions. This 
requires that nurses be trained in effective goal setting 
and problem solving. 
 Patient goals and priorities need to be reviewed and 
updated in the next appointment and the care plan 
updated.  
 The care plan should automatically timetable recall 
visits to ensure ongoing continuity of chronic disease 
management. 
 The care plan should assist with case-management 
tasks by documenting referrals to other healthcare 
specialists, acting as a communication tool between the 
healthcare teams, and allowing referrals to be 
monitored over time. 
 The care plan should provide a succinct summary of 
healthcare information, management targets, and 
personal goals to enable patients to proactively self-
manage their care, while simultaneously providing 
important information useful for emergency hospital 
visits or for visits to external health providers. 
 The care plan should contain automatic prompts so that 
all recommended checks are performed and data 
entered into the clinic’s medical records.  
 
The next steps are to extend the care plan and the TrueBlue 
model of care to cover a broader range of co-existing 
chronic diseases while still using the practice nurse as case 
manager and the care plan as the communication tool. 
Practice nurses will continue to play a central role in 
collating information from multiple sources and 
coordinating referrals. The extension of the TrueBlue 
training package will equip practice nurses to help patients 
set effective goals and identify priorities. GPs will be 
assisted with protocols for de-prescribing to reduce the 
harm from polypharmacy and align medications with 
identified patient priorities rather than following a range of 
separate single-disease guidelines. Patients will continue to 
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receive the individualised care plan that provides an 
overview of all their medical conditions and clearly states 
their priorities and the steps to be taken to achieve them. 
Monitoring will be focussed on reducing harms, maintaining 
function, and achieving the patient’s priority outcomes. 
 
Conclusions 
A care plan was designed to contain automatic prompts to 
ensure that all recommended checks formulated from 
separate chronic-disease guidelines were performed during 
the consultation. The care plan was designed to be a 
patient-readable summary of their medical conditions, 
while still remaining a suitable summary for the health team 
of information coming from multiple sources. It involved the 
participation of patients in the management of their 
diseases and summarised their priorities. The care plan was 
used successfully in the management and prioritisation of 
depression, diabetes, and heart disease during the TrueBlue 
study. 
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Figure 1: The care-plan template used by TrueBlue  
 
This template can be adapted to include other guidelines and relevant local information as required. Items in double-angle 
brackets were populated automatically from each practice’s electronic medical record and from data entered during the 
consultations. 
 
<<Practice Name>> 
<<Practice Telephone>> 
<<TRUEBLUE Care-plan/Review>> (<<Diagnosis>>) 
 
This plan should help you to better understand diabetes and heart disease. It should help plan your preventative care. 
Leaflets about diabetes, diet, exercise, foot care, and heart disease can be attached to this record. 
 
Patient’s Name: <<Patient Full Name>> Date of Birth: <<Patient DOB>> 
 
Goals to help minimise my risk factors, with help from the practice nurse and my GP: 
<< Guideline based clinical and lifestyle targets>> 
 
 
Patient goals for the next three months: 
Goal – what change do I want to 
achieve and why? 
Barriers – what will make it 
difficult? 
Enablers – what will help? 
<<Goal 1>> 
 
<<What makes it difficult 1>> <<What will help 1>> 
<<Goal 2>> 
 
<<What makes it difficult 2>> <<What will help 2>> 
<<Goal 3>> 
 
<<What makes it difficult 3>> <<What will help 3>> 
 
Three-month review: 
 
Previous goal 1 <<Previous goal 1? Met/partially met/renegotiated>> 
Previous goal 2 <<Previous goal 2? Met/partially met/renegotiated>> 
Previous goal 3 <<Previous goal 3? Met/partially met/renegotiated>> 
 
Measures Last Recorded Previous result -Comments 
Weight <<Current Weight>> kg  
Waist <<Waist size>> cm Target <94 (men), <80 (women) 
BP <<Current BP>> mmHg Target less than 130/80 
HbA1c <<Current HbA1c>>% Target less than 7.0 
Total cholesterol <<Total cholesterol>> mmol/L Target less than 4.0 
LDL <<LDL>> mmol/L Target less than 2.0 
HDL <<HDL>> mmol/L Target more than 1.0 
Triglycerides <<Triglycerides>> mmol/L Target less than 2.0 
Urine microalbuminuria << Normal/raised>>  
Last ECG <<Date of last ECG>>  
Last professional eye exam <<Last professional eye test>>  
Doppler checks of circulation 
in feet 
L  <<Doppler left Yes/No>>  
R  <<Doppler right Yes/No>>  
Foot exam (pulses, fine touch, 
skin and nails) 
<<Date of foot exam by podiatrist, 
nurse or doctor>> 
 
Exercising  <<Exercise at/above guideline>> Target 30 min per day, 5 days pw 
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Depression 
Depression can be hard to detect in people with long-term medical conditions, but it can have a big impact on their diabetes 
and heart disease. The Patient-Health Questionnaire (PHQ-9) score helps identify those who might be at risk.  
 
PHQ-9 score for depression <<PHQ-9 Score>> 
Previous episode of depression or anxiety  <<Previous depression/anxiety? Yes/No>> 
If there were previous episodes how were they 
treated? 
<<Treatment? None/medication/therapy/both>> 
Currently taking anti-depression medication? <<Taking anti-depression medication? Yes/No>> 
Currently seeing a mental health worker? <<Attending mental health worker? Yes/No>> 
 
 
MEDICAL HISTORY << Medical history>> 
 
MEDICATIONS  <<Current Medications>> 
Other medications <<Over-the-counter medications>> 
 
ALLERGIES  <<Clinical details: allergies>> 
 
ALCOHOL  <<Clinical details: alcohol>> 
 
SMOKING STATUS <<Clinical details: smoking>> 
 
REVIEW DATE:  <<Proposed review date>> 
 
REFERRALS:  <<List of referrals and area of expertise>> 
 
Doctor signature 
Doctor name:  <<Doctor Name>> 
Date:   <<GPMP date>> 
 
MORE INFORMATION 
www.heartfoundation.org.au 
www.diabetesaustralia.com.au 
www.beyondblue.org.au 
 
Quitline call 131848 
 
